| Business Summary | | ESPS,
Inc.,
doing
business
as
Liquent,
Inc.,
is
a
developer
of
publishing
software
solutions
for
document-intensive
industries.
ESPS
software
and
consulting
solutions
are
utilized
by
a
majority
of
the
world's
top
20
pharmaceutical
manufacturers
and
serves
a
growing
and
diversified
customer
base
requiring
a
robust
publishing
initiative.
Built
on
technology
that
transforms
proprietary
content
into
open
formats
such
as
XML
and
PDF,
Liquent
software
and
services
are
used
by
a
majority
of
the
top
20
global
pharmaceutical
companies.
The
Company's
solutions,
including
its
flagship
software,
CoreDossierX,
is
used
to
produce
new
drug
applications,
reports,
bids
and
proposals
and
technical
documentation. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | ESPS,
Inc.
provides
electronic
compliance
management
solutions
to
businesses
in
highly
regulated
industries,
including
the
pharmaceutical,
biotech,
chemical
and
utility
industries.
For
the
three
months
ended
6/30/01,
total
revenues
fell
28%
to
$4.5
million.
Net
loss
totaled
$3.1
million,
vs.
income
of
$300
thousand.
Revenues
reflect
a
decreased
number
of
installed
licenses.
Net
loss
also
reflects
higher
sales
and
marketing
infrastructure
costs
and
higher
personnel
expenses. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| Terrence Brennan, 49 Chairman | $259K | R. Richard Dool, 46 Pres,
CEO, Director | -- | Christopher Meshginpoosh CFO | -- | Henry Hill Sr.
VP, Client Services | -- | Margaret Archdeacon, 46 VP,
Corp. Marketing | -- | Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|